about
The mTOR signalling pathway in human cancerSpitz/Reed nevi: a review of clinical-dermatoscopic and histological correlationNuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteinsDifferential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumorsGenetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosisSDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanomaConsensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary.Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas.Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva: a study from Mozambique.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.Idiopathic infantile arterial calcification: a rare cause of sudden unexpected death in childhood.Surgical margin status and prognosis of gastrointestinal stromal tumor.Epithelial-myoepithelial parotid carcinoma after kidney transplantationEndometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors.A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomideTNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs).Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium.Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas).Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.Simultaneous presentation of Kaposi sarcoma and HHV8-associated large B-cell lymphoma in the same lymph node: A rare diagnosis in an HIV-negative patient.GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells.TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromesRestrictive dermopathy--a lethal congenital laminopathy. Case report and review of the literature.Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature.ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors.Endometrial endometrioid adenocarcinoma associated with primitive neuroectodermal tumour of the uterus: a poor prognostic subtype of uterine tumours.Angiogenesis and breast cancer.Paraganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review.Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: case report and review of the literature.Feasibility of fine-needle aspiration in the diagnosis of two unusual childhood jaw tumor types: prognoma and cementifying fibroma.Telomerase promoter mutations in cancer: an emerging molecular biomarker?Pathology, therapy and prognosis of papillary renal carcinoma.Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes.Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management.Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma.
P50
Q24627306-0CA571BC-1F4B-4680-8360-3BD70FAF82D0Q26746019-4217EE8F-7D89-4110-AFE1-C47046807BA7Q28248160-C7F5D2C5-BD4E-4E24-8ADE-DB17C9FFF0DCQ28283559-FD42D7DE-F228-415F-AF0B-944A9DAE6C93Q28396243-9E129590-B4EB-4040-91AC-B8F22ECF7A92Q33853615-2610F05D-21F6-4A82-972A-BA59AE5D6E6BQ34008909-DDB6D902-A7D2-4C56-823E-866E3FCC0E55Q34146377-08215B42-D12F-4D47-B8B2-07D44FBDF692Q34206569-B109C5A4-6C59-4410-9087-FA58B0F1424EQ34248466-BC93D694-A7CA-4CF0-8BD2-3BD828DB5F47Q34346678-5287D8D9-E8D9-439A-AB30-0C051453933BQ34595276-03042180-7656-48A4-8586-9919158BEA7DQ35602278-4474058A-DE64-4FEF-96E0-DE7C33396F05Q35739831-41E22864-079C-4B52-B1C8-6AAB95F64878Q35781382-E2AC0C7C-D4F3-40A8-88AD-38FA8CF28A17Q35837124-1A5C0A17-CA1A-4C6D-93F6-E66E18627FECQ36695151-64AFE96E-8FEC-4708-AFFA-D3BEE3815987Q36738761-FA8CBE87-59E1-45C9-A129-B1793F75D6A6Q36741113-4D6441B4-D987-44D7-9073-2D556F66E5C1Q36809668-59ABC519-F031-43BD-828D-41354D0AC0C0Q36900877-4E6E00FC-2F09-43E2-8340-CD42F98913ACQ37038150-823FBDA4-2EEA-4C4D-88A9-D02BAAF45E86Q37058301-FDD9502C-CC86-4CA1-9D9B-66E46001D704Q37093384-4F116D6D-2D2A-4C3D-9328-83483F20BF5BQ37330121-24515AF1-59DB-4BA1-B00E-26E6566AF952Q37345320-EBC581E9-C852-4571-9693-F9FE1DA0D53EQ37413877-02C4D2CE-C46C-4F53-8160-9C9A88841936Q37746699-06ED1748-ACCE-40C7-AA62-7D93C98FA016Q37761666-BD5F6CC9-550D-43B9-9E89-6D37739ACC8BQ37800804-E515C823-5903-4B25-BEBC-C4E8A777B51BQ37985598-D4A0FEFB-9A8E-475F-AD4E-77D7139547BCQ37998694-CFA01F8A-E325-4DF0-919C-F9B5E7FF6E2FQ38065702-EA993014-4888-456D-AD90-1741718F6D05Q38232447-ED21C521-093A-48FE-AE11-50B6397FD8C8Q38312048-40EC930B-C9AA-41BD-8D66-13B8DFE86F43Q38602543-59194076-06D3-4AB9-A9EC-9897C9B0592EQ38602574-907BC49C-4157-4D21-ABA5-361963A181C3Q38874710-4908C16E-FC21-4D71-9C6C-A0EF0B1F0D33Q38903424-67704122-2531-47A0-B781-97C124AD7F36Q39061082-1BF3D459-FE08-4672-97A9-098B568D2CFE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
José Manuel Lopes
@ast
José Manuel Lopes
@en
José Manuel Lopes
@es
José Manuel Lopes
@nl
José Manuel Lopes
@pt
José Manuel Lopes
@sl
type
label
José Manuel Lopes
@ast
José Manuel Lopes
@en
José Manuel Lopes
@es
José Manuel Lopes
@nl
José Manuel Lopes
@pt
José Manuel Lopes
@sl
altLabel
Jose Manuel ; José Manuel Pedr ...... s;Lopes, José Manuel PB; Lopes
@en
José Manuel Lopes
@en
Lopes, JM
@en
prefLabel
José Manuel Lopes
@ast
José Manuel Lopes
@en
José Manuel Lopes
@es
José Manuel Lopes
@nl
José Manuel Lopes
@pt
José Manuel Lopes
@sl
P106
P1153
7202733604
P1960
ObaZr68AAAAJ
P2038
Jose_Lopes22
P21
P2798
P31
P3835
jose-manuel-lopes
P496
0000-0001-8597-3474